JNK India IPO Gains Momentum, 1.03x Subscribed on Day 2!

JNK India IPO Day 2 reached 1.03x overall subscriptions, with QIBs at 0.68x, NIIs at 1.25x, and RIIs at 1.13x, reflecting growing investor interest across categories.
JNK India IPO Gains Momentum, 1.03x Subscribed on Day 2!

JNK India IPO  Day 2 saw subscriptions rise, reaching 1.03 times overall. Qualified Institutional Buyers (QIBs) subscribed 0.68 times, Non-Institutional Investors (NIIs) at 1.25 times, and Retail Individual Investors (RIIs) subscribed 1.13 times, showing increasing investor interest.

Invest in Direct Mutual Funds IPOs Bonds and Equity at ZERO COST

How To Check JNK India IPO Subscription Status? 

Steps to check the IPO subscription status on NSE

Following are the steps to check it through the NSE website

  • Visit NSE‘s official website.
  • Navigate to the ‘Market Data’ tab.
  • Choose ‘IPO’.
  • Select the JNK India Limited IPO to check its subscription status.
  • Opt for either NSE Bid details or Consolidated Bid details.
  • Explore the total number of bids received from various investors. 

JNK India Limited IPO subscription Status

JNK India IPO saw modest investor interest on its first day. Qualified Institutional Buyers (QIBs) subscribed 0.67 times, Non-Institutional Investors at 0.25 times, and Retail Individual Investors (RIIs) at 0.48 times, bringing the total day-one subscription rate to 0.49 times.

JNK India Limited IPO Allotment Status

The allotment date for the JNK India Limited IPO is set for April 26, 2024 with shares priced at a range of ₹395 to ₹415 per share and a face value of ₹2. The offering consists of lots of 36 shares, with bids accepted for these lots or their multiples.

JNK India Limited IPO Listing Date 

JNK India Limited IPO is expected to be listed on the NSE SME on April 30, 2024.

Read More News
Q4 Results में धमाकेदार प्रदर्शन से Balkrishna Industries का शेयर 13% उछला, बना रिकॉर्ड

Q4 Results में धमाकेदार प्रदर्शन से Balkrishna Industries का शेयर 13% उछला, बना रिकॉर्ड!

प्रभावशाली Q4 परिणामों के बाद, Balkrishna Industries का शेयर मूल्य 5% ऊपरी सर्किट के साथ 52-सप्ताह के उच्चतम स्तर पर पहुंच गया। EBITDA में सालाना आधार पर ग्रोथ 42% है। BSE पर स्टॉक ₹2,798.95 पर खुला।

Zydus Lifesciences Q4 Result शेयर में 5% की छलांग, मुनाफा ₹1,182 करोड़

Zydus Lifesciences Q4 Result: शेयर में 5% की छलांग, मुनाफा ₹1,182 करोड़!

Q4FY24 के लिए लगभग 300% सालाना शुद्ध लाभ वृद्धि के साथ 1,182 करोड़ रुपये की रिपोर्ट के बाद Zydus Lifesciences के शेयर 1,104.45 रुपये के रिकॉर्ड उच्च स्तर पर पहुंच गए। मजबूत EBITDA वृद्धि के कारण स्टॉक सात महीनों में 89% बढ़ गया।

Enjoy Low Brokerage Trading Account In India

Save More Brokerage!!

We have Zero Brokerage on Equity, Mutual Funds & IPO